Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pharmacogenomic Testing × CNS × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other solid neoplasm 1 CNS 1 Breast 1

Conditions

Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Magnetic Resonance Spectroscopy 37 Temozolomide 34 Specimen Handling 27 Radiotherapy 24 Biopsy 15 Radiosurgery 13 Cyclophosphamide 13 pembrolizumab 11 Radiation 10 Nivolumab 9 Bevacizumab 8 Ipilimumab 7 dinutuximab 6 abemaciclib 6 AZD 6244 6 trastuzumab deruxtecan 5 sargramostim 5 fludarabine 5 X-Rays 5 Surveys and Questionnaires 5 Eflornithine 5 Colony-Stimulating Factors 5 trametinib 4 olaparib 4 cabozantinib 4 Vincristine 4 Surgical Procedures, Operative 4 Irinotecan 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 tovorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡